Liangjing Lu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis (NCT06414135) | Liangjing Lu | 2024-06-12 |
Track Liangjing Lu automatically
Every clearance here is in the API, with alerts when new ones post.